Cargando…
Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug
Tipepidine hibenzate, a central antitussive drug, is widely used in the management of cough and is generally safe and well tolerated. We present here a case of anaphylaxis caused by this drug. When the patient had caught a cold over the previous 10 years, she had received medications, including tipe...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364787/ https://www.ncbi.nlm.nih.gov/pubmed/25802739 http://dx.doi.org/10.1002/rcr2.85 |
_version_ | 1782362129372807168 |
---|---|
author | Mochizuki, Eisuke Shirai, Toshihiro Noguchi, Rie Mitsui, Chihiro Taniguchi, Masami Suda, Takafumi |
author_facet | Mochizuki, Eisuke Shirai, Toshihiro Noguchi, Rie Mitsui, Chihiro Taniguchi, Masami Suda, Takafumi |
author_sort | Mochizuki, Eisuke |
collection | PubMed |
description | Tipepidine hibenzate, a central antitussive drug, is widely used in the management of cough and is generally safe and well tolerated. We present here a case of anaphylaxis caused by this drug. When the patient had caught a cold over the previous 10 years, she had received medications, including tipepidine hibenzate, from her family doctor. However, this time, she developed dyspnea, skin eruption, and anaphylactic shock after taking a Chinese herbal medicine and this drug. After her conditions improved due to adequate treatment, she was referred to our hospital to confirm the causative drug. Double-blind placebo-controlled oral challenge tests were performed after obtaining informed consent. Oral challenge with one-third tablet dose of tipepidine hibenzate caused a positive reaction. Urinary leukotriene E4 rose during the challenge with tipepidine hibenzate, but not with control. Clinicians should keep in mind that common antitussive drug use can cause anaphylactic reactions in very rare cases and can be harmful. |
format | Online Article Text |
id | pubmed-4364787 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BlackWell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-43647872015-03-23 Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug Mochizuki, Eisuke Shirai, Toshihiro Noguchi, Rie Mitsui, Chihiro Taniguchi, Masami Suda, Takafumi Respirol Case Rep Case Reports Tipepidine hibenzate, a central antitussive drug, is widely used in the management of cough and is generally safe and well tolerated. We present here a case of anaphylaxis caused by this drug. When the patient had caught a cold over the previous 10 years, she had received medications, including tipepidine hibenzate, from her family doctor. However, this time, she developed dyspnea, skin eruption, and anaphylactic shock after taking a Chinese herbal medicine and this drug. After her conditions improved due to adequate treatment, she was referred to our hospital to confirm the causative drug. Double-blind placebo-controlled oral challenge tests were performed after obtaining informed consent. Oral challenge with one-third tablet dose of tipepidine hibenzate caused a positive reaction. Urinary leukotriene E4 rose during the challenge with tipepidine hibenzate, but not with control. Clinicians should keep in mind that common antitussive drug use can cause anaphylactic reactions in very rare cases and can be harmful. BlackWell Publishing Ltd 2015-03 2014-12-02 /pmc/articles/PMC4364787/ /pubmed/25802739 http://dx.doi.org/10.1002/rcr2.85 Text en © 2014 The Authors. Respirology Case Reports published by John Wiley & Sons Ltd on behalf of The Asian Pacific Society of Respirology. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Case Reports Mochizuki, Eisuke Shirai, Toshihiro Noguchi, Rie Mitsui, Chihiro Taniguchi, Masami Suda, Takafumi Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug |
title | Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug |
title_full | Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug |
title_fullStr | Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug |
title_full_unstemmed | Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug |
title_short | Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug |
title_sort | anaphylaxis caused by tipepidine hibenzate, a central antitussive drug |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364787/ https://www.ncbi.nlm.nih.gov/pubmed/25802739 http://dx.doi.org/10.1002/rcr2.85 |
work_keys_str_mv | AT mochizukieisuke anaphylaxiscausedbytipepidinehibenzateacentralantitussivedrug AT shiraitoshihiro anaphylaxiscausedbytipepidinehibenzateacentralantitussivedrug AT noguchirie anaphylaxiscausedbytipepidinehibenzateacentralantitussivedrug AT mitsuichihiro anaphylaxiscausedbytipepidinehibenzateacentralantitussivedrug AT taniguchimasami anaphylaxiscausedbytipepidinehibenzateacentralantitussivedrug AT sudatakafumi anaphylaxiscausedbytipepidinehibenzateacentralantitussivedrug |